<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font30">the </span>
   <span class="font21">will </span>
   <span class="font15">for </span>
   <span class="font14">with </span>
   <span class="font13">{background </span>
   <span class="font13">studies </span>
   <span class="font13">HIV </span>
   <span class="font13">resistance </span>
   <span class="font12">integrase </span>
   <span class="font12">margin </span>
   <span class="font12">study </span>
   <span class="font12">viral </span>
   <span class="font12">{border-style </span>
   <span class="font12">The </span>
   <span class="font12">drug </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font11">patients </span>
   <span class="font11">are </span>
   <span class="font11">data </span>
   <span class="font11">review </span>
   <span class="font11">systematic </span>
   <span class="font11">treatment </span>
   <span class="font11">use </span>
   <span class="font11">"the </span>
   <span class="font11">HIV- </span>
   <span class="font11">Sub-Saharan </span>
   <span class="font11">[]. </span>
   <span class="font11">bias </span>
   <span class="font11">mutations </span>
   <span class="font11">this </span>
   <span class="font11">dolutegravir </span>
   <span class="font11">regimens </span>
   <span class="font11">Health </span>
   <span class="font11">INSTI </span>
   <span class="font11">included </span>
   <span class="font11">level </span>
   <span class="font11">may </span>
   <span class="font11">outcomes </span>
   <span class="font11">rate </span>
   <span class="font11">that </span>
   <span class="font10">International </span>
   <span class="font10">This </span>
   <span class="font10">according </span>
   <span class="font10">from </span>
   <span class="font10">help </span>
   <span class="font10">inhibitors </span>
   <span class="font10">px; </span>
   <span class="font10">search </span>
   <span class="font10">{font-family </span>
   <span class="font10">Additional </span>
   <span class="font10">African </span>
   <span class="font10">Available </span>
   <span class="font10">[], </span>
   <span class="font10">all </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">assess </span>
   <span class="font10">each </span>
   <span class="font10">effect </span>
   <span class="font10">eligible </span>
   <span class="font10">file </span>
   <span class="font10">font-size </span>
   <span class="font10">have </span>
   <span class="font10">management </span>
   <span class="font10">not </span>
   <span class="font10">regimens. </span>
   <span class="font10">risk </span>
   <span class="font10">studies. </span>
   <span class="font10">subtypes </span>
   <span class="font10">Africa. </span>
   <span class="font10">Conference </span>
   <span class="font10">DTG </span>
   <span class="font10">DTG-based </span>
   <span class="font10">Literature </span>
   <span class="font10">Microsoft </span>
   <span class="font10">[Internet]. </span>
   <span class="font10">al. </span>
   <span class="font10">alafenamide </span>
   <span class="font10">also </span>
   <span class="font10">authors </span>
   <span class="font10">been </span>
   <span class="font10">double; </span>
   <span class="font10">following </span>
   <span class="font10">from: </span>
   <span class="font10">include </span>
   <span class="font10">missing </span>
   <span class="font10">other </span>
   <span class="font10">published </span>
   <span class="font10">quality </span>
   <span class="font10">resistance-associated </span>
   <span class="font10">reviews </span>
   <span class="font10">using </span>
   <span class="font10">would </span>
   <span class="font10">"drug </span>
   <span class="font10">AIDS </span>
   <span class="font10">Cochrane </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">Data </span>
   <span class="font10">Ngoufack </span>
   <span class="font10">These </span>
   <span class="font10">among </span>
   <span class="font10">available </span>
   <span class="font10">baseline </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">conducted </span>
   <span class="font10">effects </span>
   <span class="font10">evidence </span>
   <span class="font10">genetic </span>
   <span class="font10">has </span>
   <span class="font10">individual </span>
   <span class="font10">inhibitor-based </span>
   <span class="font10">into </span>
   <span class="font10">living </span>
   <span class="font10">models </span>
   <span class="font10">our </span>
   <span class="font10">randomized </span>
   <span class="font10">results </span>
   <span class="font10">reviewers </span>
   <span class="font10">solid; </span>
   <span class="font10">sources </span>
   <span class="font10">strand </span>
   <span class="font10">suppression </span>
   <span class="font10">tenofovir </span>
   <span class="font10">transfer </span>
   <span class="font10">under </span>
   <span class="font10">which </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Africa </span>
   <span class="font10">Excel </span>
   <span class="font10">Ezechiel </span>
   <span class="font10">INSTI-based </span>
   <span class="font10">Jagni </span>
   <span class="font10">Joseph </span>
   <span class="font10">LINK </span>
   <span class="font10">Lancet </span>
   <span class="font10">Mar </span>
   <span class="font10">Medical </span>
   <span class="font10">Ndze, </span>
   <span class="font10">Ngum </span>
   <span class="font10">RAL </span>
   <span class="font10">SSA </span>
   <span class="font10">Semengue, </span>
   <span class="font10">Study </span>
   <span class="font10">Trials </span>
   <span class="font10">Two </span>
   <span class="font10">University </span>
   <span class="font10">Valantine </span>
   <span class="font10">WHO </span>
   <span class="font10">[cited </span>
   <span class="font10">adherence </span>
   <span class="font10">adults </span>
   <span class="font10">adverse </span>
   <span class="font10">analyses </span>
   <span class="font10">any </span>
   <span class="font10">article </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">characteristics </span>
   <span class="font10">countries </span>
   <span class="font10">courier; </span>
   <span class="font10">data. </span>
   <span class="font10">duration </span>
   <span class="font10">em; </span>
   <span class="font10">emtricitabine, </span>
   <span class="font10">evidences </span>
   <span class="font10">explore </span>
   <span class="font10">found </span>
   <span class="font10">grid.. </span>
   <span class="font10">https://linkinghub.elsevier.com/retrieve/pii/S. </span>
   <span class="font10">immune </span>
   <span class="font10">independently </span>
   <span class="font10">infection </span>
   <span class="font10">initial </span>
   <span class="font10">its </span>
   <span class="font10">knowledge </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">multicentre, </span>
   <span class="font10">non-randomized </span>
   <span class="font10">patient </span>
   <span class="font10">people </span>
   <span class="font10">present </span>
   <span class="font10">process </span>
   <span class="font10">protocol </span>
   <span class="font10">pt;} </span>
   <span class="font10">raltegravir </span>
   <span class="font10">refers </span>
   <span class="font10">relevant </span>
   <span class="font10">resolved </span>
   <span class="font10">such </span>
   <span class="font10">suppression,ï¿½? </span>
   <span class="font10">third </span>
   <span class="font10">through </span>
   <span class="font10">tool </span>
   <span class="font10">viruses </span>
   <span class="font10">while </span>
  </p>
 </body>
</html>
